SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-068981
Filing Date
2024-06-04
Accepted
2024-06-04 19:12:33
Documents
1
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3886
  Complete submission text file 0000950170-24-068981.txt   5492
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1999
Korro Bio, Inc. (Issuer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KORRO BIO, INC. ONE KENDALL SQUARE. BUILDING 600-700 CAMBRIDGE MA 02139
Business Address
Olugemo Olukemi (Reporting) CIK: 0002022212 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39062 | Film No.: 241020164